JPRN-UMIN000043115招募中未知
Coronary Plaque Characterization by Near-infrared Spectroscopy for Identification of Plaque Vulnerability: Association with Coronary Computed Tomographic Angiography - Coronary Plaque Characterization by NIRS: Association with CCTA
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Prior coronary revascularization therapy (PCI and/or CABG) to target vessel 2.STEMI within the past 24 hours 3.Simultaneously treated with multi-vesssel PCI on initial procedure 4.LMT case 5.Chronic kidney disease (serum creatinine on admission more than 1.5 mg/dl) 6.Presented with hemodynamic instability (cardiogenic shock) 7.Complex lesion which need to do balloon dilatation (more than 2.0mm balloon or debulking device before pre-procedural NIRS-IVUS 8.Poor image quality case which the technician cannot perform either CTA or NIRS-IVUS measurements 9.Lesions with an EEM diameter <2.0mm
研究者
相似试验
招募中
不适用
Coronary Plaque Characterization by Near-infrared Spectroscopy for Identification of Plaque Vulnerability: Association with Coronary Computed Tomographic AngiographyIschemic Heart DiseaseJPRN-UMIN000042883Gifu Heart Center120
已完成
不适用
Coronary Artery Plaque Characterisation with Non-invasive Multi-Slice Computed Tomography and Invasive Intravascular Ultrasound and Optical Coherence Tomography in Patients with Acute Coronary Syndromes Without ST-segment Elevatio10011082atherosclerosisNL-OMON36442niversitair Medisch Centrum Groningen50
已完成
2 期
SPECTACL: SPECTroscopic Assessment of Coronary LipidAngina, UnstableMyocardial InfarctionAngina PectorisNCT00330928Infraredx106
已完成
3 期
High-Resolution Assessment of Coronary Plaques in a Global Evolocumab Randomized Study (HUYGENS)anginaheart attackhigh blood lipidshigh cholesterolVessels supplying the heart with blood1001108210013317NL-OMON48805Amgen43
进行中（未招募）
1 期
Imaging of Coronary Plaques in Subjects Treated With EvolocumabDyslipidemiaEUCTR2017-003236-37-DEAmgen Inc.150